Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
Amgen (AMGN) announced that the U.S. FDA has approved Uplizna as the first and only treatment for adults living with ...